Update on monoclonal antibody therapy in chronic lymphocytic leukemia.

Clive S. Zent, Neil E. Kay

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Monoclonal antibodies are an evolving treatment modality in chronic lymphocytic leukemia that has the potential to provide more effective and safer targeted therapy. This review provides historical context and detailed analysis of current developments, as well as an outline for future prospects and expectations in this exciting new arena of therapeutics.

Original languageEnglish (US)
Pages (from-to)107-113
Number of pages7
JournalClinical advances in hematology & oncology : H&O
Issue number2
StatePublished - Feb 2004

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'Update on monoclonal antibody therapy in chronic lymphocytic leukemia.'. Together they form a unique fingerprint.

Cite this